| Document |
Document Title |
|
WO/2024/097572A1 |
In some examples, a gastroretentive system includes a dissolvable outer capsule, a body disposed within the outer capsule, at least one expandable and collapsible member coupled to the body and configured to be disposed within the outer ...
|
|
WO/2024/097437A1 |
An implant (11) placed through the lacrimal caruncle (10) of a patient for prolonged delivery of a drug to the eye (1) for treating conditions such as glaucoma. The implant can include a drug-carrying depot which elutes the drug at a sub...
|
|
WO/2024/091534A1 |
An implantable encapsulated device for implantation into a body includes a chamber encapsulated at least in part by a permeable membrane and including a supportive scaffold for holding one of patient and donor derived cells within the ch...
|
|
WO/2024/088272A1 |
A spray nozzle (90) and a spray apparatus, the spray nozzle (90) comprising a body (1), the body (1) being provided with an air supply channel (11) and a liquid supply channel (12), and the air supply channel (11) comprising a front sect...
|
|
WO/2024/089284A1 |
An oral drug delivery device (100) comprising a housing (102) having a longitudinal axis (104) and extending from a first end to a second end, a first attachment part (110) having a first distal end (112) and a first proximal end (114), ...
|
|
WO/2024/086013A1 |
The present disclosure relates generally to ingestible devices containing anti-interleukin antibodies that bind to one or both of human interleukin-23 and human interleukin-12, such as ustekinumab, wherein the devices are structured and ...
|
|
WO/2024/077996A1 |
A nasal drug delivery device with adjustable positions is disclosed. The device comprises: an intranasal locking connector (120), a nasal dropper (200), a syringe pump (300) and a syringe (400). One end of the nasal dropper (200) is mova...
|
|
WO/2024/073791A1 |
The present invention is directed to delivery devices for deploying an insertable into an orifice guided by digit, the delivery device comprising: an insertable orientation means having a first longitudinal axis and a base portion, the i...
|
|
WO/2024/076900A1 |
A drug delivery implant may include an implant body and a core comprising a pharmaceutical agent. The core can be located within the implant body that extends longitudinally and circumferentially around the core. The implant body can als...
|
|
WO/2024/076578A1 |
A contrast delivery system for determining tissue capture of a shunt device (1506) includes a catheter (1540) including a lumen having a distal end, an exit hole connecting the lumen to an exterior surface of the catheter, and a side ope...
|
|
WO/2024/072671A1 |
Systems and methods are provided relating to a low power high-volume efficient integrated ingestible capsule drug delivery system for targeted or localized ultrasound-mediated drug delivery within the GI tract. The high-volume efficiency...
|
|
WO/2024/062232A1 |
An implantable device (101) for drug delivery to a patient, the device comprising a housing (103) defining an enclosed space (106), a catheter port (102) that provides fluid access to the enclosed space, a permeable release zone (105) th...
|
|
WO/2024/062311A1 |
Presented herein are techniques for monitoring a state, amount, and/or concentration of a therapeutic substance in, for example, an implantable component of an implantable medical device. In particular, an implantable component can inclu...
|
|
WO/2024/064603A1 |
The present disclosure provides a drug delivery device. The drug delivery device is taken orally by a patient, and then activates within the gastrointestinal (GI) tract of the patient. Upon activation, arms of the drug delivery device ex...
|
|
WO/2024/062466A1 |
This disclosure concerns expandable devices, specifically self- deployed devices that are designed to be ingested to and deployed in the gastrointestinal tract and configured for controlled disintegration. The devices contain expandable ...
|
|
WO/2024/055927A1 |
The present invention relates to a medical catheter, which comprises a catheter main body and a bending control component. The catheter main body comprises a proximal end part and a distal end part located at a distal end of the catheter...
|
|
WO/2024/055929A1 |
The present invention relates to a medical interventional catheter, which comprises a catheter body that integrates diagnosis and treatment. The catheter body comprises a functional part located at the distal end. The functional part is ...
|
|
WO/2024/054721A1 |
A bidirectional electroosmotic pump may be provided. The bidirectional electroosmotic pump may be made of materials that are biocompatible and non-ferrous. The bidirectional electroosmotic pump may be part of an implantable medical devic...
|
|
WO/2024/049667A1 |
Systems and methods are provided relating to a low power ingestible capsule drug delivery system for targeted or localized ultrasound-mediated drug delivery within the GI tract. The high volume efficiency low power ingestible capsule dru...
|
|
WO/2024/050089A1 |
A device for dispensing medicine to an eye from a container in a non-gravitational manner includes a housing defining a space for receiving the container of medicine. A pair of motors is provided on the housing on opposite sides of the r...
|
|
WO/2024/045982A1 |
Provided are a drug carrier balloon catheter and a method for preparing same, a balloon catheter system, and a method for intravascular in-situ stent generation. The drug carrier balloon catheter comprises: a catheter 100 having a distal...
|
|
WO/2024/042462A1 |
Embodiments of the invention provide an auto-inflatable patch assembly for drug delivery within a lumen, having: a pliable and inflatable patch having water and gas-impermeable walls, which define an internal chamber and an array of pene...
|
|
WO/2024/038123A1 |
A capsule device (100.1) suitable for ingestion, comprising: a) a capsule housing (110, 120), b) a tissue penetrating member (130) arranged for advancement along an axis in a distal direction, c) a drive member (160) for advancing the ti...
|
|
WO/2024/038420A1 |
An apparatus, including an array of electrodes and an implantable therapeutic substance reservoir, wherein the apparatus is an implantable portion of a cochlear implant, the apparatus is configured so that the therapeutic substance reser...
|
|
WO/2024/038122A1 |
A capsule device (100.2) suitable for ingestion, comprising: a) a capsule housing (110, 120), b) a tissue penetrating member (130) held by a hub (150, 160, 162) for advancing the tissue penetrating member (130) axially from a first posit...
|
|
WO/2024/032688A1 |
Provided is a medicament delivery apparatus (100) with an automatic protection apparatus (70), which comprises: a medicament cylinder (10), provided with a proximal end (11), a distal end (12), and a chamber (13) for accommodating a soli...
|
|
WO/2024/032686A1 |
The present invention provides a medicament delivery device with an anti-needling function, comprising: a medicine cylinder, provided with a proximal end, a distal end, and a chamber located between the proximal end and the distal end an...
|
|
WO/2024/021769A1 |
It provides a spray head and a device for intranasal spraying of liquid medicine, comprising: a nozzle (3), which has a flow channel (31) running through the axial direction, and the distal and proximal ends of the flow channel (31) are ...
|
|
WO/2024/019760A1 |
A tract expander includes a base having a threaded central hole and a plurality of wings. The base and the wings are connected by a plurality of hinges. Each of the plurality of hinges is connected to the base and to a wing of the plural...
|
|
WO/2024/017545A1 |
The present invention relates to a disposable applicator system for inserting a solid dosage form into a body canal such as a vaginal or rectal canal. The applicator system consists of an applicator unit and a blister pack from which the...
|
|
WO/2024/015467A1 |
Methods and systems are provided for trans-cervical delivery of agents for various purposes, including contraception and tubal patency evaluation. The trans-cervical delivery system comprises at least one port; a tubular shaft coupled to...
|
|
WO/2024/010801A1 |
An article for applying a lavage fluid to a surface, the article having a sealed body for housing a lavage fluid, wherein the sealed body is configured to be self-supported before and during the discharge of the lavage fluid from the sea...
|
|
WO/2024/006844A1 |
A device for delivery of a drug into cerebrospinal fluid of a brain including a hollow container having a reservoir volume and an outlet, the container having an upper surface and a lower surface; a porous structure having a sintered rig...
|
|
WO/2024/000578A1 |
Provided is a manual nasal irrigation assembly, comprising a mixing cup (10), a nasal irrigation bottle (20), and a stirring rod (30). The interior of the mixing cup (10) is provided with a mixing cavity (11). A cup opening (12) communic...
|
|
WO/2023/248722A1 |
A pharmaceutical liquid injection unit 1 comprises a tube 10. The tube 10 includes: a center lumen 11; at least three puncture catheter ports 12a to 12c that are in communication with the center lumen 11 and open at different circumferen...
|
|
WO/2023/241403A1 |
The present invention relates to a ventricular function assistance device, a delivery and recovery system, and a ventricular function assistance system. The ventricular function assistance system comprises the ventricular function assist...
|
|
WO/2023/279007A9 |
A device is disclosed for occluding an anatomical passage between first and second anatomical structures. The device includes a tip portion having a proximal element connected to a distal element through a member. The proximal element an...
|
|
WO/2023/234381A1 |
A transfer instrument (10) facilitates the transfer of a medical sheet (300) to a transplantation target part (402) of a heart (400). The transfer instrument (10) comprises: a first carrier member (18) including a first shaft (24) and a ...
|
|
WO/2023/234380A1 |
This transfer instrument (10) transfers a medical sheet (300) to a transplant destination part (402) of a heart (400). The transfer instrument (10) comprises: a first carrier member (18) which has a first support part (26) and a first sh...
|
|
WO/2023/230619A1 |
The present invention provide a pharmaceutical intervention in neonatal to infantile pigs, ruminants, and other livestock that inhibits the activation of the HPG axis, growth of the gonads and inhibits gonadal production of sex hormones,...
|
|
WO/2023/230302A1 |
A lumen ablation system provides a method of treating varicose veins with a pair of balloons to isolate a section of lumen. A toroid access balloon is configured proximal to a lumen access aperture. An isolation balloon is configured an ...
|
|
WO/2023/224197A1 |
The present invention relates to a micro-structured body employing a gyroid form in triply periodic minimal surface (TPMS) structures by using two-photon polymerization (TPP), and to a driving method therefor. The use of the present inve...
|
|
WO/2023/220479A1 |
Systems, methods and apparatus for atomizing a topical and spraying both a user's skin and a microneedle roller. The microneedle roller can be off-axis from a needle axis thereby allowing the roller to either precede atomized topical rea...
|
|
WO/2023/213026A1 |
Provided is an intranasal spraying apparatus, comprising a body. One or two spraying nozzles are arranged at a distal end of the body. A limiting ventilation member is arranged on each spraying nozzle so as to limit the insertion depth o...
|
|
WO/2023/214260A1 |
Device (1) for the passive release of a substance into a solution, said device allowing the tracking of the release by means of intra body communication, and comprising a transmitter (2) configured to generate an alternating electrical s...
|
|
WO/2023/215753A1 |
Cannula and device implantation systems are provided. In some embodiments, cannula members are provided that comprise membranes to prevent and reduce infection. Cannulas of the present disclosure are operable to be provided as indwelling...
|
|
WO/2023/211394A1 |
The invention relates to a local treatment kit (A) for use in the treatment of solid and hollow organ cancers, which is configured to apply a drug in an appropriate dose to be administered to a cancerous organ of a patient without hospit...
|
|
WO/2023/208148A1 |
Provided are an administration device and an accessory thereof. The administration device comprises an airflow generation assembly (1) and an air outlet pipe (200). The airflow generation assembly comprises a cylinder body (110) and a fi...
|
|
WO/2023/212367A2 |
|
|
WO/2023/192903A1 |
Exemplary winged capsules for delivery of a substance to an animal is provided. The winged capsules can include a capsule defining a central axis and an inner space adapted to contain the substance. A capsule retainer can include a centr...
|
